| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| holding | EW | Common Stock | 37,426 | 03 May 2022 | Direct |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| holding | EW | Employee Stock Option (Right to Acquire) | 03 May 2022 | Common Stock | 14,925 | $45.28 | Direct | F1 | ||||||
| holding | EW | Employee Stock Option (Right to Acquire) | 03 May 2022 | Common Stock | 50,700 | $59.26 | Direct | F2 | ||||||
| holding | EW | Employee Stock Option (Right to Acquire) | 03 May 2022 | Common Stock | 46,200 | $72.68 | Direct | F3 | ||||||
| holding | EW | Employee Stock Option (Right to Acquire) | 03 May 2022 | Common Stock | 37,400 | $93.10 | Direct | F4 | ||||||
| holding | EW | Performance Rights | 03 May 2022 | Common Stock | 5,350 | $0.000000 | Direct | F5 | ||||||
| holding | EW | Performance Rights | 03 May 2022 | Common Stock | 6,375 | $0.000000 | Direct | F6 | ||||||
| holding | EW | Performance Rights | 03 May 2022 | Common Stock | 7,200 | $0.000000 | Direct | F7 |
| Id | Content |
|---|---|
| F1 | These options were granted on May 17, 2018 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one year after the grant date in four equal annual installments. |
| F2 | These options were granted on May 8, 2019 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one year after the grant date in four equal annual installments. |
| F3 | These options were granted on May 7, 2020 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one year after the grant date in four equal annual installments. |
| F4 | These options were granted on May 4, 2021 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one year after the grant date in four equal annual installments. |
| F5 | Reflects the target number of shares (the Target Award) covered by restricted stock units granted on May 4, 2021 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and scheduled to vest on May 4, 2024. The number of restricted stock units that vest will depend upon achievement of certain performance goals over a three-year performance period and will range from 0% to 175% of the Target Awards. |
| F6 | Reflects the target number of shares (the Target Award) covered by restricted stock units granted on May 7, 2020 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and scheduled to vest on May 7, 2023. The number of restricted stock units that vest will depend upon achievement of certain performance goals over a three-year performance period and will range from 0% to 175% of the Target Awards. |
| F7 | Reflects the target number of shares (the Target Award) covered by restricted stock units granted on May 8, 2019 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and scheduled to vest on May 8, 2022. The number of restricted stock units that vest will depend upon achievement of certain performance goals over a three-year performance period and will range from 0% to 175% of the Target Awards. |
Exhibit 24, Power of Attorney, attached.